ATE299370T1 - Carnitin und inositolphosphat enthaltende zusammensetzung als diätzusatz oder arzneimittel - Google Patents

Carnitin und inositolphosphat enthaltende zusammensetzung als diätzusatz oder arzneimittel

Info

Publication number
ATE299370T1
ATE299370T1 AT00922866T AT00922866T ATE299370T1 AT E299370 T1 ATE299370 T1 AT E299370T1 AT 00922866 T AT00922866 T AT 00922866T AT 00922866 T AT00922866 T AT 00922866T AT E299370 T1 ATE299370 T1 AT E299370T1
Authority
AT
Austria
Prior art keywords
carnitin
composition containing
dietary supplement
medicinal product
inositol phosphate
Prior art date
Application number
AT00922866T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE299370T1 publication Critical patent/ATE299370T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AT00922866T 1999-04-22 2000-04-19 Carnitin und inositolphosphat enthaltende zusammensetzung als diätzusatz oder arzneimittel ATE299370T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000248A IT1306133B1 (it) 1999-04-22 1999-04-22 Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en) 1999-04-22 2000-04-19 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (1)

Publication Number Publication Date
ATE299370T1 true ATE299370T1 (de) 2005-07-15

Family

ID=11406708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922866T ATE299370T1 (de) 1999-04-22 2000-04-19 Carnitin und inositolphosphat enthaltende zusammensetzung als diätzusatz oder arzneimittel

Country Status (26)

Country Link
US (1) US6565876B1 (de)
EP (1) EP1119363B1 (de)
JP (1) JP2002542282A (de)
KR (1) KR20010053023A (de)
CN (1) CN1359295A (de)
AR (1) AR023391A1 (de)
AT (1) ATE299370T1 (de)
AU (1) AU776591B2 (de)
BR (1) BR0006076A (de)
CA (1) CA2335015C (de)
DE (1) DE60021247T2 (de)
DK (1) DK1119363T3 (de)
EE (1) EE200000742A (de)
ES (1) ES2243254T3 (de)
HU (1) HU227357B1 (de)
IL (1) IL140164A0 (de)
IS (1) IS5763A (de)
IT (1) IT1306133B1 (de)
NO (1) NO20006429L (de)
PL (1) PL197885B1 (de)
PT (1) PT1119363E (de)
SI (1) SI1119363T1 (de)
SK (1) SK19322000A3 (de)
TN (1) TNSN00083A1 (de)
TR (1) TR200003737T1 (de)
WO (1) WO2000064426A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316997B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) * 2000-07-06 2017-10-12 Beiersdorf Ag Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) * 2001-06-19 2003-01-09 Beiersdorf Ag Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20090169585A1 (en) * 2003-10-23 2009-07-02 Resveratrol Partners, Llc Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
WO2006102060A1 (en) * 2005-03-18 2006-09-28 Oxyplus, Inc. Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
ES2280136B1 (es) * 2006-02-17 2008-08-16 Universitat De Les Illes Balears Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) * 2007-10-31 2013-09-04 花王株式会社 筋力向上剤
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP2012508267A (ja) * 2008-11-11 2012-04-05 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ セルライトの処置に有用な化合物
EP2582368B1 (de) * 2010-06-16 2018-05-09 Alfasigma S.p.A. Acetyl-L-carnitin zur Erhöhung der Neurogenese in neuronalem Gewebe
ES2495666B1 (es) * 2013-03-15 2015-08-10 Laboratoris Sanifit, S.L. Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) * 2018-11-12 2020-08-06 주식회사 노암 항암용 조성물
TW202110437A (zh) * 2019-05-23 2021-03-16 美商希諾瓦有限責任公司 用於酒精誘發之皮膚潮紅之治療及緩解的組成物及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5626849A (en) * 1995-06-07 1997-05-06 Reliv International, Inc. Weight loss composition for burning and reducing synthesis of fats
EP1021177A4 (de) * 1997-02-04 2002-05-15 John V Kosbab Zusammensetzungen und verfahren zur verhütung und behandlung von vaskulär-degeneratieve krankheiten
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) * 1997-11-04 1999-05-18 Oncologics, Inc. Green nutritional powder composition

Also Published As

Publication number Publication date
US6565876B1 (en) 2003-05-20
AR023391A1 (es) 2002-09-04
SI1119363T1 (en) 2005-10-31
CA2335015A1 (en) 2000-11-02
NO20006429L (no) 2001-02-20
BR0006076A (pt) 2001-03-20
AU776591B2 (en) 2004-09-16
JP2002542282A (ja) 2002-12-10
DE60021247T2 (de) 2006-04-27
PL197885B1 (pl) 2008-05-30
ES2243254T3 (es) 2005-12-01
HUP0102926A2 (hu) 2002-03-28
EE200000742A (et) 2002-04-15
IT1306133B1 (it) 2001-05-30
EP1119363A2 (de) 2001-08-01
HUP0102926A3 (en) 2002-12-28
SK19322000A3 (sk) 2001-06-11
ITRM990248A1 (it) 2000-10-22
KR20010053023A (ko) 2001-06-25
DE60021247D1 (de) 2005-08-18
NO20006429D0 (no) 2000-12-15
IS5763A (is) 2000-12-08
DK1119363T3 (da) 2005-10-17
AU4313500A (en) 2000-11-10
TNSN00083A1 (fr) 2005-11-10
EP1119363B1 (de) 2005-07-13
TR200003737T1 (tr) 2001-07-23
PT1119363E (pt) 2005-09-30
WO2000064426A2 (en) 2000-11-02
IL140164A0 (en) 2002-02-10
CN1359295A (zh) 2002-07-17
CA2335015C (en) 2008-03-18
PL346160A1 (en) 2002-01-28
WO2000064426A3 (en) 2001-05-25
HU227357B1 (en) 2011-04-28

Similar Documents

Publication Publication Date Title
HUP0103513A3 (en) Novel amidine derivatives their preparation and application as medicines and pharmaceutical compositions containing same
ITMI951021A0 (it) Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
HUP0104195A3 (en) Vitamin d analogues, preparation thereof, pharmaceutical and cosmetic compositions containing them
AU2792997A (en) Medicinal compositions for topical administration containing vitamin d and vitamin k
IL118369A0 (en) Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
ZA94345B (en) C7 Taxane derivatives and pharmaceutical compositions containing them
IL135177A0 (en) Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL144977A0 (en) Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
HUP9601161A2 (en) Use of retinoids in cosmetic compositions or for the manufacture of pharmaceutical compositions
IL164022A0 (en) Phosphate derivatives of fluoroxindole and pharmaceutical compositions containing the same
PL363807A1 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
DE69800469D1 (de) Pulverförmige ascorbinsaüre enthaltende kosmetische und/oder dermatologische zusammensetzung
IL165775A0 (en) Novel quinuclidine derivatives and medicinal compositions containing the same
HUP9901344A3 (en) Radicicol derivatives and pharmaceutical compositions thereof
DE60021247D1 (de) Carnitin und inositolphosphat enthaltende zusammensetzung als diätzusatz oder arzneimittel
HU9800147D0 (en) Isoxasol-and crotonoil-amide derivatives and pharmaceutical and diagnostical compositions containing them
HUP0103381A3 (en) Disubstituted maleimide compounds and medicinal utilization thereof and the pharmaceutical compositions containing the same
ZA961779B (en) Aromatic heterocyclic compounds pharmaceutical and cosmetic compositions containing them and uses thereof
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0000042A3 (en) Omega-3-fatacid and vitamin containing meet product
IL148807A0 (en) Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same
HUP0100102A3 (en) Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
IL118427A (en) N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics and pharmaceutical compositions comprising them
GB9820815D0 (en) Improvementsin or relating to nutritional and pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1119363

Country of ref document: EP